5,555 followers
New Research: Etoricoxib as a treatment of choice for patients with SLCO2A1 mutation exhibiting autosomal recessive primary hypertrophic osteoarthropathy: A case report: We reported a 22-year-old Emirati male with autosomal recessive primary… https://t.co/